Real-world data analysis of PD-L1 expression and overall survival (OS) in advanced non-small cell lung cancer (aNSCLC)

被引:0
|
作者
Staib, J. [1 ]
Sudarsanam, S. [2 ]
Byfield, S. Dacosta [1 ]
Kennedy, C. [1 ]
Weiss, L. [3 ]
机构
[1] UnitedHlth Grp, Res & Dev, Minnetonka, MN USA
[2] NeoGen Labs, Data Sci, Aliso Viejo, CA USA
[3] NeoGen Labs, Pathol, Aliso Viejo, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
76P
引用
收藏
页码:27 / 27
页数:1
相关论文
共 50 条
  • [1] Shifting treatment landscape and overall survival (OS) by PD-L1 expression level among patients (pts) with advanced non-small cell lung cancer (aNSCLC)
    Dietz, H.
    Wu, N.
    Ge, W.
    Quek, R. G.
    Pouliot, J-F.
    Antonia, S. J.
    Jalbert, J.
    Harnett, J.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1399 - S1400
  • [2] Shifting treatment landscape and overall survival by PD-L1 expression level among patients with advanced non-small cell lung cancer (ansclc)
    Ge, Wenzhen
    Dietz, Hilary
    Wu, Ning
    Quek, Ruben G. W.
    Pouliot, Jean-Francois
    Antonia, Scott
    Jalbert, Jessica
    Harnett, James
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 296 - 296
  • [3] Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: a Real-World Australian Perspective
    Prabhakaran, S.
    Russell, P. A.
    Farrall, A. L.
    Asadi, K.
    Barrett, W.
    Cooper, C.
    Cooper, W.
    Duhig, E. E.
    Egan, M.
    Fox, S.
    Godbolt, D.
    Gupta, S.
    Cotton, S.
    Leslie, C.
    Leong, T.
    Moffat, D.
    Qiu, M.
    Sivasubramaniam, V.
    Snell, C.
    Skerman, J.
    Walsh, M.
    Whale, K.
    Klebe, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S479 - S479
  • [4] Real-world prospective data of small biopsy samples for tumor PD-L1 expression in non-small cell lung cancer
    Morikawa, K.
    Tsunoda, A.
    Inoue, T.
    Mineshita, M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [5] Overall survival (OS) in advanced non-small cell lung cancer (aNSCLC) patients treated with frontline chemotherapy or immunotherapy by comorbidity: A real-world data (RWD) collaboration.
    Rivera, Donna R. R.
    Lasiter, Laura
    Christian, Jennifer
    Enewold, Lindsey
    Espirito, Janet L.
    Hansen, Eric
    Henk, Henry J.
    Kushi, Lawrence H.
    Lane, Daniel
    Natanzon, Yanina
    Benito, Ruth Pe
    Rasmussen, Erik
    Robert, Nicholas J.
    Stewart, Mark
    Sweetnam, Connor
    Tymejczyk, Olga
    Valice, Emily
    Wagner, Joseph
    Zander, Alia
    Allen, Jeff
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Real-world treatment sequencing in advanced non-small cell lung cancer (aNSCLC).
    Radtchenko, Janna
    Feinberg, Bruce A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Real-world treatment patterns before and after receiving PD-l1 test results in patients with advanced non-small cell lung cancer (aNSCLC)
    Ge, Wenzhen
    Antonia, Scott
    Wu, Ning
    Pouliot, Jean-Francois
    Dietz, Hilary
    Jalbert, Jessica
    Quek, Ruben Gw
    Harnett, James
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 111 - 112
  • [8] Real-World PD-L1 Testing Patterns for Patients with Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S660 - S660
  • [9] Real-world treatment patterns before and after receiving PD-L1 test results in patients (pts) with advanced non-small cell lung cancer (aNSCLC)
    Antonia, S. J.
    Wu, N.
    Ge, W.
    Pouliot, J-F.
    Dietz, H.
    Jalbert, J.
    Quek, R. G.
    Harnett, J.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1419 - S1420
  • [10] Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer.
    Leapman, Michael
    Presley, Carolyn J.
    Zhu, Weiwei
    Soulos, Pamela R.
    Adelson, Kerin B.
    Boffa, Daniel J.
    Gross, Cary Philip
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)